Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
105,373,335
-
Shares change
-
-2,301,127
-
Total reported value, excl. options
-
$699,630,313
-
Value change
-
-$17,077,199
-
Put/Call ratio
-
2.12%
-
Number of buys
-
42
-
Number of sells
-
-54
-
Price
-
$6.64
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q4 2018
142 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2018.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 105,373,335 shares
of 363,214,619 outstanding shares and own 29.01% of the company stock.
Largest 10 shareholders include Artal Group S.A. (60,240,864 shares), FMR LLC (14,739,614 shares), BlackRock Inc. (4,356,726 shares), Ulys, L.L.C. (4,321,214 shares), Vanguard Group Inc (2,985,162 shares), UBS ASSET MANAGEMENT AMERICAS INC (2,942,423 shares), NEA Management Company, LLC (2,382,286 shares), STATE STREET CORP (1,846,498 shares), Clearbridge Investments, LLC (1,249,590 shares), and SECTOR GAMMA AS (862,602 shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.